Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
BMJ 379:e071380 Altintas Dogan AD, Hilberg O, Hess S, Jensen TT, Bladbjerg EM, Juhl CB (2022) Respiratory effects of treatment with a Glucagon-Like Peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease
Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now
Human pilot studies have measured short-term symptom reports and basic safety labs
In order to find more specific targets and additional treatment options for people with asthma, COPD, or CF, a greater understanding of the regulation of mucus secretion by neuropeptides is undeniably important
US$ 29.66
US$ 25.00
US$ 20.89
US$ 29.59
US$ 24.04
